Epigallocatechin-3-gallate Delivered in Nanoparticles Increases Cytotoxicity in Three Breast Carcinoma Cell Lines

[Image: see text] The anticancer activity of epigallocatechin-3-gallate (EGCG), orally administrated, is limited by poor bioavailability, absorption, and unpredictable distribution in human tissues. EGCG charged nanoparticles may represent an opportunity to overcome these limitations. We assayed two...

Descripción completa

Detalles Bibliográficos
Autores principales: Farabegoli, Fulvia, Granja, Andreia, Magalhães, Joana, Purgato, Stefania, Voltattorni, Manuela, Pinheiro, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685782/
https://www.ncbi.nlm.nih.gov/pubmed/36440117
http://dx.doi.org/10.1021/acsomega.2c01829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685782/
https://www.ncbi.nlm.nih.gov/pubmed/36440117
http://dx.doi.org/10.1021/acsomega.2c01829

Ejemplares similares